Pharmafile Logo

responsive web design (RWD)

- PMLiVE

Safety review shows ‘no evidence’ that AZ’s vaccine causes increased risk of blood clots

AZ's vaccine continues to be backed by the EMA and the EMA’s Pharmacovigilance Risk Assessment Committee

- PMLiVE

bluebird bio reveals long-term data for Lenti-D gene therapy in CALD

At 24 months of follow-up, 90% of patients were free of major functional disabilities

- PMLiVE

McCann Health appoints Adriano Botter as global chief digital officer

Botter previously served as digital director for McCann Health Brazil

CRYOPORT APPOINTS MIND+MATTER AS PART OF A GLOBAL BRAND DEVELOPMENT TENDER

Cryoport Inc has appointed creative communications agency Mind+Matter, an Ashfield Health company, part of UDG Healthcare as its strategic marketing partner to support the rebrand of the entire business alongside...

Inizio

- PMLiVE

Novavax COVID-19 vaccine found to be 86% effective against UK variant

Phase 2b trial also finds vaccine efficacy of 55.4% against South Africa variant

- PMLiVE

Red Havas Health launch unites health professionals from across the globe

Red Havas has announced the launch of Red Havas Health

- PMLiVE

FDA advisory committee to review oncology accelerated approvals

Review comes after voluntary indication withdrawals for a number of cancer therapies

- PMLiVE

J&J’s one-dose COVID-19 vaccine granted EU authorisation

Company aiming to begin vaccine delivery to EU in the second half of April

- PMLiVE

EMA says there is ‘no indication’ AZ/Oxford’s COVID-19 vaccine causes blood clots

Agency’s safety committee added vaccine’s benefits continue to outweigh risks

- PMLiVE

Bedrock announces a number of new hires

Appointments include Emily Wigginton who joins as head of client services

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links